Navigation Links
USDA's Decision Thursday on Genetically Engineered Alfalfa -- Leahy and DeFazio Warn About USDA Decision Lifting All Protections for Organic and Conventional Farmers

WASHINGTON, Jan. 27, 2011 /PRNewswire-USNewswire/ -- Following are the comments of Senator Patrick Leahy (D-Vt.) and Congressman Peter DeFazio (D-Ore.) on USDA's announcement Thursday that the agency will completely remove current regulations that limit use of genetically engineered (GE) alfalfa, a key commodity in dairy farming, including organic dairy farming, making alfalfa the first perennial GE crop approved for widespread planting. Leahy and DeFazio have led congressional efforts to limit the threat to organic farmers of widely introducing "Roundup Ready" genetically engineered alfalfa. The two lawmakers last June headed a letter to Agriculture Secretary Tom Vilsack, asking that alfalfa's regulated status be retained in USDA's pending rulemaking on GE alfalfa. Leahy and DeFazio also are the co-authors of the 1990 legislation that created the national organic standards and labeling program and continue to champion the growth and success of the U.S. organic industry.

Joint Statement

Of Senator Patrick Leahy (D-Vt.)

And Representative Peter DeFazio (D-Ore.)

On USDA's Decision On Genetically Engineered Alfalfa

Thursday, January 27, 2011

"This long approval process began as a search for a workable compromise, but it has ended as a surrender to business as usual for the biotech industry. USDA officials had an opportunity to address the concerns of all farmers, whether they choose to farm genetically altered crops, conventional crops, or organic crops, and to find a way for them to coexist. Instead, what we now have is a setback for the nation's organic and conventional agriculture sectors. Instead of settling this issue, USDA's decision regrettably guarantees further rounds in the courts.

"This is a big payday for the giant firms that pushed for this rollback. Unfortunately, consumers and hardworking farmers who choose not to use these genetically engineered crops will be handed the tab. Organic feed already is expensive and in short supply. This will compound that problem while creating many more.

"America's biotech industry and organic agriculture can coexist and thrive, but only if there are clear rules to referee their conflicting needs and interests."

SOURCE Office of U.S. Senator Patrick Leahy
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Second Edition of Biotechnology and the Federal Circuit Examines the Courts Decisions on Chemical, Biotechnology, and Pharmaceutical Patent Law Cases
2. Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately
3. Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors
4. Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
5. Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView
6. Report Details How States Respond to Citizens United Decision
7. Pew Faults Marine Stewardship Councils Decision
8. Responding to OCS Drilling Decision, Advocacy Group Challenges President to "Get Serious" About Energy Independence and Security
9. Industry Leaders from Blue Coat, Oracle, Polycom, Siemens and Taleo Headline SiriusDecisions Sales and Marketing Summit 2010
10. Tool identifies infection clusters; rate of T cell drop not helpful in decision to start treating HIV
11. Cautious Approach Needed Before Any Decision on EU Out-of-Quota Sugar Exports Is Taken
Post Your Comments:
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Neurocrine ... Kevin Gorman , President and CEO of Neurocrine ... Jaffray Healthcare Conference in New York ... encouraged to visit the website approximately 5 minutes prior ... software.  A replay of the presentation will be available ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
(Date:11/24/2015)... 24, 2015  Asia-Pacific (APAC) holds the third-largest ... market. The trend of outsourcing to low-cost locations ... higher volume share for the region in the ... margins in the CRO industry will improve. ... ( ), finds that the market earned ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
Breaking Biology Technology:
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... NEW YORK , Oct. 27, 2015 ... the major issues of concern for various industry verticals ... This is due to the growing demand for secure ... practices in various ,sectors, such as hacking of bank ... concerns for electronic equipment such as PC,s, laptops, and ...
Breaking Biology News(10 mins):